Results 201 to 210 of about 31,146 (236)
Some of the next articles are maybe not open access.

Cardioprotection

Der Anaesthesist, 2012
The demographic change is associated with an increasing number of elderly patients with serious comorbidities. The prevalence of coronary heart disease in particular increases with age and raises the risk of perioperative myocardial ischemia. In the last few years various interventions have been evaluated to lower the perioperative risk for serious ...
David J. Lefer, Roberto Bolli
openaire   +3 more sources

Tocotrienols in Cardioprotection

2007
Tocotrienols, a group of Vitamin E stereoisomers, offer many health benefits including their ability to lower cholesterol levels, and provide anticancer and tumor-suppressive activities. Several recent studies determined the cardioprotective abilities of tocotrienols, although the number is only 1% compared to the study with tocopherols.
Samarjit, Das   +2 more
openaire   +3 more sources

The Importance of Autophagy in Cardioprotection

High Blood Pressure & Cardiovascular Prevention, 2013
Autophagy is an intracellular lysosomal-mediated catabolic process in which senescent or damaged proteins and organelles are sequestered by double membrane-limited vesicles called autophagosomes, and then degraded by lysosomes. While the role of autophagy in different pathological states is context-dependent, it has been shown that during cardiac ...
SCIARRETTA, SEBASTIANO   +4 more
openaire   +3 more sources

Cardioprotective MicroRNAs

Pediatric Cardiology, 2011
MicroRNAs (miRNAs) are involved in almost every aspect of a mammalian cell's functionality, from stem cell differentiation to aging and pathogenesis; however, their role in immediate cell signaling is less defined. This has been recently demonstrated by the rapid increase or decrease of miR-21's abundance within minutes of activation or inhibition of ...
openaire   +2 more sources

Sildenafil and Cardioprotection

Current Pharmaceutical Design, 2013
The phosphodiesterese-5 (PDE5) inhibitors, including sildenafil (Viagra™), vardenafil (Levitra™), tadalafil (Cialis™) and avanafil (Stendra™) have been developed for the treatment of erectile dysfunction. Moreover, sildenafil and tadalafil have been approved for the management of pulmonary arterial hypertension.
openaire   +2 more sources

Antioxidants and Cardioprotection

Medicine & Science in Sports & Exercise, 2007
Limiting myocardial ischemia-reperfusion (IR) injury is essential for preventing contractile dysfunction and limiting morbidity and mortality associated with ischemic heart disease. Over the last few decades, it has become clear that during IR insults, myocardial oxygen radical formation is accelerated and plays a critical role in mediating cellular ...
openaire   +2 more sources

Cardioprotection by volatile anesthetics

Vascular Pharmacology, 2005
Preconditioning describes a very powerful endogenous mechanism by which the heart may be protected against ischemia and reperfusion injury. Transient administration of a volatile anesthetic before a prolonged ischemic episode reduces myocardial infarct size to a degree comparable to that observed during ischemic preconditioning.
Martin W, Bienengraeber   +4 more
openaire   +2 more sources

Thyroid Hormone and Cardioprotection

Comprehensive Physiology, 2016
ABSTRACT The heart is a major target of thyroid hormones, with maintenance of euthyroid hormone balance critical for proper function. In particular, chronic low thyroid function can eventually lead to dilated heart failure with impaired coronary blood flow.
Anthony Martin, Gerdes, Kaie, Ojamaa
openaire   +2 more sources

Phytoestrogens as Cardioprotective Agents

Cardiology in Review, 2005
Epidemiologic studies have shown that women with a higher dietary intake of phytoestrogens, plant-derived compounds with partial estrogen agonist properties, have a lower incidence of cardiovascular disease and breast and uterine cancer than women with a lower dietary intake of these substances.
Denise, Park   +2 more
openaire   +2 more sources

Targeting adiponectin for cardioprotection

Expert Opinion on Therapeutic Targets, 2006
Adiponectin is an adipose tissue-derived plasma protein which has a reduced concentration in subjects with obesity-related diseases. Adiponectin has antidiabetic and anti-inflammatory characteristics, which lead to beneficial actions on various obesity-linked complications.
Noriyuki, Ouchi   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy